Starwatch Consumer | Nissan SUVs’ steering under review; Toyota is No. 1 brand in Japan ; FDA rejects diet drug;
The government has opened an investigation into Nissan Pathfinder and Infiniti QX4 sport utility vehicles over reports of corrosion that can lead to the loss of steering.

Read more on The Kansas City Star

Orexigen’s Contrave: An Obesity Drug Timeline
In advance of Monday’s decision, a look at Contrave’s journey up to now.

Read more on The Motley Fool

FDA Panel Recommends Approval for Weight Loss Drug
An FDA panel has recommended approval of Orexigen Therapeutics Inc.’s weight loss drug Contrave, making it the first in group of competitors to get a positive nod from experts

Read more on Fox News

Lunch and learn on prescription drug abuse
WAYNESVILLE — Haywood Regional Health & Fitness Center will hold a Lunch and Learn session on prescription drug abuse noon-1:30 p.m. Tuesday, Nov. 30.

Read more on Asheville Citizen-Times